The gas field that straddles a border: Cyprus and Israel race an October clock
Nicosia and Jerusalem aim to close the Aphrodite-Ishai compensation deal by end-October, while Chevron pushes engineering toward a final investment decision. A sliver of reservoir, a decade of diplomacy.
Published 29 September 2026 · 06:00 GMT

Key facts
- Cyprus and Israel are aiming to conclude the Aphrodite-Ishai agreement by end-October, formalizing compensation for the part of the reservoir extending into Israel's Ishai licence. Cyprus Mail; Bosphorus News
- Chevron and partners have entered Front-End Engineering Design (FEED) toward a Final Investment Decision; the FEED program runs about $106 million. NewMed Energy
- Aphrodite holds ~5.6 trillion cubic feet of gas in place; a few percent extends into Israeli waters. An international expert would determine Israel's share for a one-time payment. Cyprus Hydrocarbons Service; NewMed filing
- The export route runs through Egypt: a term sheet with EGAS covers all recoverable gas at 700 million cubic feet per day, priced against Brent, delivered to Port Said. NewMed; Egyptian Petroleum Ministry
- Shell agreed July 31 to sell its 35% Aphrodite stake to MOL for up to $720 million; FID is penciled for 2027–2028, first gas for 2031. Shell; MOL; NewMed
Some gas fields are just geology. Aphrodite is diplomacy with a reservoir attached. The field — 5.6 trillion cubic feet of it, almost entirely in Cypriot waters — extends by a few percent into Israel's Ishai licence, and that sliver has taken a decade to price. Now Nicosia and Jerusalem are racing an end-October clock to close the compensation deal, while Chevron's engineers push toward the investment decision that would finally build it.
The mechanism under discussion is elegant in its simplicity. Aphrodite would be developed entirely by the Cypriot-side partnership — Chevron operating, with NewMed and soon MOL as partners — while Israel and the Ishai licence holders receive a one-time payment for their share of the reservoir. An international expert determines the share; the money settles the geology. No joint operation, no shared control, no maritime boundary redrawn.
The argument is older than the field's name. Aphrodite was discovered at the end of 2011, in the first flush of Eastern Mediterranean excitement, when a drillship working Cyprus's Block 12 hit gas that the explorers quickly sized in the trillions of cubic feet. From the earliest seismic surveys, the geologists could see that the reservoir did not respect the maritime boundary drawn on the charts: a tongue of it — a few percent of the whole — crossed into the Israeli-licensed waters next door, where the Ishai licence sat. The two governments began talking about compensation almost immediately. Fifteen years later, they are still talking — and for the first time, they are talking with a calendar.
That longevity is the story. Governments changed in Nicosia and in Jerusalem. The company that found the field sold out — Noble Energy, which drilled the discovery well, was absorbed by Chevron in 2020, and the American major inherited both the asset and the argument. Cyprus cycled through energy ministers and strategies. Israel went through five elections in four years. Each restart of the talks carried the files of the last one, and each new negotiator had to be convinced that the old compromises still held. The wonder is not that the deal took a decade; it is that the underlying facts never changed, so the deal never died.
There is a precedent now, and it sits just up the coast. In October 2022, Israel and Lebanon — two countries formally at war — signed a US-mediated maritime boundary agreement that unlocked the Qana prospect and let the Karish field produce. The lesson Nicosia and Jerusalem drew was not about the terms, which differ, but about the possibility: maritime files in this basin can close. The Aphrodite-Ishai mechanism borrows the same spirit — define the geology, price the difference, and leave the flags where they are.
What the expert decides, in the end, is a number. The reservoir is mapped with seismic surveys and appraisal wells; geologists model its shape, its thickness, the porosity of the rock and the pressure of the gas inside. From that model comes an apportionment: so many billion cubic feet under the Cypriot licence, so many under the Israeli one. The international expert both sides have discussed turns that model into a share, and the share into a single payment. It is the same logic the industry applies whenever a reservoir straddles a line: unitize the field in accounting terms even when you cannot unitize it in political ones. Israel does not co-own Aphrodite. It is paid for its sliver, once, and the field is developed as a Cypriot project.
The choreography this month has been deliberate. President Christodoulides met Chevron's Javier La Rosa in New York on September 22 and pressed for implementation over planning; Egypt's petroleum minister met the same Chevron executive the same day to accelerate the export arrangements. When the buyer, the operator and the host president all meet in the same week, the calendar is not coincidental.
The FEED program — Front-End Engineering Design, the roughly $106 million effort NewMed has disclosed — is where a gas field stops being a presentation and starts being a shopping list. FEED produces the detailed engineering: the platform or subsea layout, the pipeline route to Port Said, the processing specifications, the procurement packages that contractors will bid on, and — critically — a cost estimate accurate enough for boards to bet billions on. It is the most expensive homework in the industry, and it is also the point of no return in slow motion: companies do not spend nine figures engineering fields they do not intend to build.
Few projects illustrate the gap between a handshake and a hydrocarbon like Aphrodite's timeline. A final investment decision — FID, the moment the partners formally commit the capital — is penciled for 2027 in MOL's announcement and 2028 on NewMed's project page. First gas follows in 2031 either way. Christodoulides presses for faster; the engineers price reality. Between FEED and first gas lie procurement, construction, the installation seasons, and commissioning — a chain with no shortcuts, only sequencing.
Aphrodite is diplomacy with a reservoir attached.
Egypt is the quiet center of this story. The commercial structure already initialled with EGAS covers all of Aphrodite's recoverable gas — 700 million cubic feet a day to Port Said, priced against Brent within an agreed floor and ceiling, feeding Egypt's LNG export system. The field's route to market does not run through the Ishai talks; it runs through Cairo. The Israeli agreement removes an obstacle; Egypt is the destination.
Cairo's interest is structural, not sentimental. Egypt built two LNG export terminals — at Idku and Damietta — that made it the Eastern Mediterranean's gas shopfront, and those terminals need feedstock. Egypt's own production has to serve a domestic market that grows every year, and the arithmetic of export capacity plus domestic demand is what makes Cypriot gas valuable to Cairo: 700 million cubic feet a day of Aphrodite gas, landed at Port Said under a Brent-linked price with an agreed floor and ceiling, is feedstock bought at a formula both sides can live with. The floor protects the sellers when oil crashes; the ceiling protects the buyer when it spikes. That is the commercial heart of the EGAS term sheet — and it is why the Israeli negotiation, however delicate, is not the commercial core of the project. The gas was always going to Cairo.
The ownership is shifting under the diplomacy. Shell agreed on July 31 to sell its 35% stake — held through BG Cyprus — to Hungary's MOL for up to $720 million, a deal expected to close in early 2027. MOL's announcement penciled FID in 2027; NewMed's project page says 2028. Both point to first gas in 2031. Christodoulides is pressing for faster; the engineers are pricing reality.
The ownership change tells its own story about the majors' decade. Shell came to Aphrodite through its 2016 acquisition of BG Group, which held the 35% stake; ten years on, the supermajor is pruning its Eastern Mediterranean exposure while smaller, hungrier players step in. MOL — Hungary's national oil and gas company, now expanding aggressively upstream — is buying in for up to $720 million, a price that values the field's promise rather than its production, since there is none yet. The deal is expected to close in early 2027, neatly ahead of the FID window: MOL wants its seat at the table before the capital commitment is made.
For Cyprus, Aphrodite has been the longest wait in the country's economic history. Discovered in 2011, appraised, argued over, re-appraised — and still, fifteen years on, not a cubic foot sold. The field is supposed to be the moment Cyprus joins the ranks of gas producers, with state revenues, royalties, and the geopolitical weight that comes with molecules Europe wants. Every Cypriot president since the discovery has promised to accelerate it; Christodoulides, meeting Chevron's Javier La Rosa in New York on September 22, pressed for implementation over planning — the same demand, in sharper language. The October target for the Ishai deal is, in Nicosia's reading, the removal of the last excuse.
Beneath the surface, the wider dispute hasn't moved. Türkiye maintains that Turkish Cypriots have equal rights over the island's resources and holds separate maritime claims in the Eastern Mediterranean — though Turkish official reporting does not claim the Block 12 area itself. The Aphrodite-Ishai deal settles a bilateral sliver; the island's larger hydrocarbon argument continues.
The Turkish position is the file's permanent background radiation. Ankara's line — equal rights for Turkish Cypriots over the island's resources, plus its own maritime claims — frames every Cypriot energy decision, even when, as with Block 12, the disputed zones do not overlap the field. The distinction matters: the Aphrodite-Ishai agreement settles an accounting question between two states that recognize each other, while the island's larger hydrocarbon dispute — the one involving the north, the south, and Ankara — continues on its own track, untouched by whatever is signed in October.
The Israeli ambassador in Nicosia, Oren Anolik, has cautioned against treating a signature as the finish line: an agreement establishes the principles, and then the mechanism for calculating Israel's share must be applied. Previous target dates have slipped. End-October is a target, not a deadline — but it is the most serious target this file has had in years.
Why should this target hold when the others slipped? The optimists' answer is the choreography of September: the buyer is signed, the operator is spending, the ownership is consolidating, and the host president, the buyer and the operator converged on New York in the same week. Previous targets were diplomatic; this one is commercial — there is money moving underneath the communiqués. The pessimists' answer is the ambassador's: an agreement sets principles, and principles then have to survive the expert's arithmetic, two governments' lawyers, and the calendar of ratification. End-October is a target, not a deadline — but it is the most serious target this file has had in years.
And then there is the question nobody in the September meetings raised in public: 2031. First gas is penciled for a year in which Europe's climate plans say gas demand should be falling, not rising. The industry's answer is that LNG is the transition fuel, that Egypt's terminals and Asia's buyers will absorb the molecules regardless, and that a field developed in the 2030s produces into the 2050s. The critics' answer is the stranded-asset arithmetic: every year of delay narrows the window in which a new gas field pays back its billions. Aphrodite's decade of diplomacy has a cost measured not only in lawyers' hours but in the shrinking of its own commercial horizon. That, more than any single negotiation, is why Nicosia wants speed.
Western coverage — the energy press, Cyprus Mail — reads the October target as the Eastern Mediterranean gas story finally maturing: a decade of discoveries, disputes and delays converging on actual investment decisions. The frame is commercial — FEED, FID, first gas 2031 — and the Ishai deal is presented as the last political precondition.
The Western lens also watches the MOL entry. A Hungarian company buying into Cypriot gas via a Shell exit is, in this reading, Central Europe diversifying away from Russian molecules — the energy-security logic that has driven every Eastern Mediterranean deal since 2022.
The Western lens also counts the lawyers' decade as a feature, not a bug. In this telling, the fact that two states spent years designing a compensation mechanism instead of drilling first and arguing later is the Eastern Mediterranean growing up: investment-grade diplomacy for investment-grade capital. The $106 million FEED program is the market's vote — money does not do detailed engineering on political fantasies.
And the West watches the calendar for a second reason: 2031. If Aphrodite produces on schedule, its gas reaches a European market still weaning itself off pipeline dependence — the energy-security logic that has driven every Eastern Mediterranean deal since 2022, now with a Hungarian buyer in the consortium to prove the point.
Eastern coverage reads Aphrodite as a footnote to the region's real energy war. Russian commentary treats Eastern Mediterranean gas as marginal — 5.6 trillion cubic feet is a rounding error against Siberian reserves — and the decade of diplomacy over a sliver of reservoir as evidence of Western energy fragmentation.
The Eastern lens also notes the American operator. Chevron runs the field, American diplomacy hovers over the talks, and the gas flows to Egypt's LNG plants — in this reading, Aphrodite is another node in the US-managed energy architecture of the Eastern Mediterranean.
The Eastern lens dwells on the asymmetry. Fifteen years of negotiation over a few percent of one field, in this reading, is what energy dependence looks like from the outside: a region that must import its diplomacy along with its molecules, because it never built the pipeline politics of a producer. Moscow's commentary treats the October target the way it treats every Eastern Mediterranean deadline — as a date that will be renegotiated, because the underlying balance of power has not changed.
The East also reads the American fingerprints. Chevron operates, Washington's diplomats hover, the gas flows to Egyptian LNG plants that sell into markets America wants supplied — Aphrodite, in this telling, is not a Cypriot field or an Israeli sliver but a node in an architecture. The compensation mechanism is elegant, the East concedes; it is also, in this reading, the house rules of someone else's house.
The Global South lens — Al Jazeera, the Egyptian press — reads the story from Cairo. For Egypt, Aphrodite is feedstock for its LNG export terminals and leverage in its eternal energy balancing act. The 700 million cubic feet a day to Port Said is not a footnote; it is the point.
The South's structural observation is about the compensation mechanism itself: an international expert, a one-time payment, no redrawn borders. For a region where resource disputes usually end in conflict, the Aphrodite formula — price the sliver, don't fight over it — is presented as a model worth copying.
The South's lens lingers on the precedent. Maritime Africa and Southeast Asia are full of straddling reservoirs that became straddling conflicts; a formula that prices the sliver through an expert and a one-time payment, without moving a single maritime boundary, is — in the South's reading — a technology of peace as much as a commercial mechanism. The October target is treated as a test: if even this decade-old file can close, the model travels.
And the South counts what the North discounts: time. For Egypt, 700 million cubic feet a day is not a footnote to European energy security; it is industrial feedstock, export revenue, and leverage in the permanent negotiation with its own growing demand. The field's route to market runs through Port Said, not through Brussels — and in the South's telling, that is the real headline, with the diplomacy as the supporting act.
The stakes, stripped of communiqués, are three. First, whether two small states can close a file that has outlasted governments in both capitals — a test of whether the Eastern Mediterranean's diplomacy can keep pace with its geology. Second, whether the money follows: FEED to FID to first gas, a chain in which each link costs more than the last, ending in 2031 with molecules the market still wants. Third, whether the formula travels — price the sliver, don't fight over it — to the other maritime boundaries where reservoirs refuse to respect the lines on the chart. October will answer the first. The other two will take the decade Aphrodite has already spent waiting.
The consensus
- What we agree on
- All three blocs agree on the facts: Cyprus and Israel target end-October for the Aphrodite-Ishai compensation agreement; Chevron's FEED program (~$106M) is advancing toward FID; the field holds ~5.6 TCF with a few percent in Israeli waters; the Egypt export route (700M cf/d to Port Said) is initialled; Shell is selling its 35% to MOL for up to $720M.
- What we don't agree on
- They disagree on the significance: the West sees a maturing gas province; the East sees a marginal field in America's energy architecture; the South sees Cairo's feedstock and a model for pricing disputes.
- What we know
- We know the mechanism — Cypriot development, one-time Israeli payment, expert-determined share. We know the commercial route runs through Egypt regardless.
- What we don't know yet
- We don't know whether end-October holds — previous targets slipped — or whether FID lands in 2027 or 2028.
- What we expect
- We expect the agreement to close close to target — the choreography of September says so — and expect the real fight to move to the FID timeline.
Sources
- Cyprus Mail; Bosphorus News
- NewMed Energy
- Cyprus Hydrocarbons Service; NewMed filing
- NewMed; Egyptian Petroleum Ministry
- Shell; MOL; NewMed